drugset / Trial / NCT02043704

RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain

NCT02043704 ↗

Phase 4 Completed 100 enrolled TriHealth Inc.
RandomizedParallel-groupTriple-blindSupportive care

Summary

This randomized controlled trial will evaluate the effects of perioperative intravenous (IV) acetaminophen on postoperative narcotic consumption and pain scores in subjects undergoing vaginal reconstructive surgery. One hundred subjects will be randomly assigned to receive either IV acetaminophen or IV placebo. Those in the IV acetaminophen group will receive 1000mg IV every 6 hours for 24 hours beginning prior to anesthesia induction. The control group will receive placebo saline infusions at the same time intervals. All subjects will receive as needed (prn) IV narcotic for additional pain relief. Visual analog scales (VAS) regarding pain will be evaluated at 18 and 24 hours postoperative and immediately prior to discharge. We will also collect total IV narcotic consumption. We hypothesize that subjects receiving IV acetaminophen will have lower VAS scores and decreased total narcotic consumption in comparison to the control group.

Timeline

Start
2014-01
Primary completion
2016-08
Completion
2016-08

Outcome

Missed primary endpoint

registry analysis (equivalence test); IV Acetaminophen vs Saline; p = 0.328; Wilcoxon (Mann-Whitney); note: The p-value was not adjusted for multiple comparisons. NCT02043704 ↗

paper Furthermore, pain with activity and numeric rating scale-assessed pain scales were similar (P = 0.328; P = 0.597). PMID 28230615 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg Intravenous

Indications

No indication recorded.